RxDoctor Payments Data

Sami Hourieh, MD

Family Medicine · Branson West, MONPI 1770165706

Payments from drug & device makers

$696in general payments, 2019–2025

Across 24 payments — averaging $28.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$245
  • Exact Sciences$153
  • Dexcom, Inc.$95
  • Novo Nordisk$45
  • Globus Medical$43
  • Astellas Pharma US Inc$31
  • plus $83 from 4 others

What the payments were for

  • Food & beverage$696100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$696 in reported general payments places this provider in the 55th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$4,983
Medicare patients
58
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide16$17,447
JardianceEmpagliflozin21$16,947
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$684
Albuterol Sulfate HfaAlbuterol Sulfate23$635
Gabapentin33$467
Methocarbamol34$427
Atorvastatin Calcium62$386
Losartan Potassium26$307
Omeprazole32$291
Levothyroxine Sodium43$244
Ipratropium Bromide11$239
Oxycodone Hcl20$220
Rosuvastatin Calcium17$207
Sertraline Hcl15$192
Metoprolol Tartrate18$191

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$45$17,44716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Branson West

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →